| Ms Debra R Schuelke, RN, MSN, FNP-BC | |
|
30 Porter Dr, Middlebury, VT 05753-8422 | |
| (802) 388-4001 | |
| (802) 388-3474 |
| Full Name | Ms Debra R Schuelke |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 30 Porter Dr, Middlebury, Vermont |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831247212 | NPI | - | NPPES |
| 3609696 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 8237 (Tennessee) | Primary |
| Entity Name | University Of Tn Medical Center Home Care Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619197365 PECOS PAC ID: 0648369819 Enrollment ID: O20101215001203 |
News Archive
Hemosphere, Inc., a private medical device company, has completed a late round of venture capital financing totaling $9.3 million. The company has developed the HeRO® Vascular Access Device, which provides access for hemodialysis - the process of filtering waste products from blood when kidneys are in renal failure - similar to a conventional graft.
The New York Times reports that federal officials are investigating whether a dozen drug and device makers "made illegal payments to doctors and health officials in foreign countries." Although pharmaceutical companies routinely contract with doctors in the United States to be consultants, experts say the situation is more complex overseas because "in much of the rest of the world, doctors are government employees. And even consulting arrangements that would be considered routine in the United States might violate the Foreign Corrupt Practices Act, particularly if the payments are outsize or the arrangements are not disclosed to the governments.
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that it will present preclinical data demonstrating VB-111's potential synergy and additive therapeutic effect when administered in combination with the conventional chemotherapy cancer treatments.
Global health consultant Alanna Shaikh writes in this post on the Global Network for Neglected Tropical Diseases' "End the Neglect" blog about the elimination of river blindness, or onchoceriasis, from Colombia and progress made against the disease in Mexico and Guatemala.
› Verified 6 days ago
| Entity Name | Morristown-hamblen Homecare And Hospice, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417117300 PECOS PAC ID: 1557438397 Enrollment ID: O20101215001239 |
News Archive
Hemosphere, Inc., a private medical device company, has completed a late round of venture capital financing totaling $9.3 million. The company has developed the HeRO® Vascular Access Device, which provides access for hemodialysis - the process of filtering waste products from blood when kidneys are in renal failure - similar to a conventional graft.
The New York Times reports that federal officials are investigating whether a dozen drug and device makers "made illegal payments to doctors and health officials in foreign countries." Although pharmaceutical companies routinely contract with doctors in the United States to be consultants, experts say the situation is more complex overseas because "in much of the rest of the world, doctors are government employees. And even consulting arrangements that would be considered routine in the United States might violate the Foreign Corrupt Practices Act, particularly if the payments are outsize or the arrangements are not disclosed to the governments.
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that it will present preclinical data demonstrating VB-111's potential synergy and additive therapeutic effect when administered in combination with the conventional chemotherapy cancer treatments.
Global health consultant Alanna Shaikh writes in this post on the Global Network for Neglected Tropical Diseases' "End the Neglect" blog about the elimination of river blindness, or onchoceriasis, from Colombia and progress made against the disease in Mexico and Guatemala.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Debra R Schuelke, RN, MSN, FNP-BC 30 Porter Dr, Middlebury, VT 05753-8422 Ph: (802) 388-4001 | Ms Debra R Schuelke, RN, MSN, FNP-BC 30 Porter Dr, Middlebury, VT 05753-8422 Ph: (802) 388-4001 |
News Archive
Hemosphere, Inc., a private medical device company, has completed a late round of venture capital financing totaling $9.3 million. The company has developed the HeRO® Vascular Access Device, which provides access for hemodialysis - the process of filtering waste products from blood when kidneys are in renal failure - similar to a conventional graft.
The New York Times reports that federal officials are investigating whether a dozen drug and device makers "made illegal payments to doctors and health officials in foreign countries." Although pharmaceutical companies routinely contract with doctors in the United States to be consultants, experts say the situation is more complex overseas because "in much of the rest of the world, doctors are government employees. And even consulting arrangements that would be considered routine in the United States might violate the Foreign Corrupt Practices Act, particularly if the payments are outsize or the arrangements are not disclosed to the governments.
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that it will present preclinical data demonstrating VB-111's potential synergy and additive therapeutic effect when administered in combination with the conventional chemotherapy cancer treatments.
Global health consultant Alanna Shaikh writes in this post on the Global Network for Neglected Tropical Diseases' "End the Neglect" blog about the elimination of river blindness, or onchoceriasis, from Colombia and progress made against the disease in Mexico and Guatemala.
› Verified 6 days ago
Rachel A Guy, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 102 Court St, Middlebury, VT 05753 Phone: 802-388-2765 | |
Mary Gill, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 110 Porter Drive, Middlebury, VT 05753 Phone: 802-388-7959 Fax: 802-388-8136 | |
Stacy Ann Macfarlane, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 115 Porter Dr, Middlebury, VT 05753 Phone: 802-388-4701 | |
Laura Wilkinson, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 116 Porter Dr, Middlebury, VT 05753 Phone: 802-388-8805 Fax: 802-388-5619 | |
Leslie Gerdinier Orelup, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 44 Collins Dr, Suite 201, Middlebury, VT 05753 Phone: 802-388-1500 Fax: 802-388-0441 | |
Kathleen Lombard, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 44 Collins Dr Ste 202, Middlebury, VT 05753 Phone: 802-388-1338 Fax: 802-388-8244 | |
Louisa Veazie Pratt, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 115 Porter Dr, Middlebury, VT 05753 Phone: 802-388-4701 |